4 results match your criteria: "National Fukuyama Hospital[Affiliation]"
Intern Med
April 2005
Department of Cardiology, National Fukuyama Hospital, Fukuyama.
Nihon Naika Gakkai Zasshi
June 2000
Department of Internal Medicine, National Fukuyama Hospital.
Gan To Kagaku Ryoho
March 1994
Dept. of Obstetrics and Gynecology, National Fukuyama Hospital.
Primary aggressive cyto-reduction followed by adjuvant chemotherapy has so far been the standard treatment modality for advanced ovarian cancer. However, as cisplatin-containing regimens have been shown to generate high efficacy rates, a new modality involving extirpation of the tumor after chemotherapy, rather than surgery as the first treatment, has become available for patients with stage III or IV ovarian cancer in whom tumor cells may remain after surgery. In our examination of 56 cases, higher efficacy rates, higher tumor-debulking rates, lower frequency of extended surgery and longer median survival time were obtained with preoperative chemotherapy in comparison with postoperative chemotherapy.
View Article and Find Full Text PDFActa Otolaryngol Suppl
March 1995
Division of Otolaryngology, National Fukuyama Hospital, Japan.
We studied the development of the pharynx in human embryos and fetuses. Embryos and fetuses from 4.5 mm crown-rump length (CRL) to 40 mm CRL were processed for microscopic examination.
View Article and Find Full Text PDF